ArticleDiscover oncology2025

Immunometabolism signature derived from on-treatment tumor specimens predicts immune checkpoint blockade response in metastatic melanoma.

Shuzhao Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.